Vaishali Pharma Limited (VAISHALI) - Net Assets

Latest as of March 2026: Rs691.15 Million INR ≈ $7.47 Million USD

Based on the latest financial reports, Vaishali Pharma Limited (VAISHALI) has net assets worth Rs691.15 Million INR (≈ $7.47 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs1.23 Billion ≈ $13.34 Million USD) and total liabilities (Rs542.74 Million ≈ $5.87 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Vaishali Pharma Limited tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs691.15 Million
% of Total Assets	56.01%
Annual Growth Rate	28.07%
5-Year Change	162.26%
10-Year Change	1686.62%
Growth Volatility	112.58

Vaishali Pharma Limited - Net Assets Trend (2013–2026)

This chart illustrates how Vaishali Pharma Limited's net assets have evolved over time, based on quarterly financial data. See Vaishali Pharma Limited (VAISHALI) liquidity interval to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Vaishali Pharma Limited (2013–2026)

The table below shows the annual net assets of Vaishali Pharma Limited from 2013 to 2026. For live valuation and market cap data, see Vaishali Pharma Limited market cap and net worth.

Year	Net Assets	Change
2026-03-31	Rs691.15 Million ≈ $7.47 Million	+6.47%
2025-03-31	Rs649.16 Million ≈ $7.02 Million	+51.53%
2024-03-31	Rs428.39 Million ≈ $4.63 Million	+5.69%
2023-03-31	Rs405.31 Million ≈ $4.38 Million	+53.79%
2022-03-31	Rs263.54 Million ≈ $2.85 Million	+17.56%
2021-03-31	Rs224.19 Million ≈ $2.42 Million	+4.85%
2020-03-31	Rs213.81 Million ≈ $2.31 Million	-0.08%
2019-03-31	Rs213.99 Million ≈ $2.31 Million	+3.87%
2018-03-31	Rs206.02 Million ≈ $2.23 Million	+432.55%
2017-03-31	Rs38.69 Million ≈ $418.36K	+18.89%
2016-03-31	Rs32.54 Million ≈ $351.88K	+0.58%
2015-03-31	Rs32.35 Million ≈ $349.85K	+5.25%
2014-03-31	Rs30.74 Million ≈ $332.40K	+10.84%
2013-03-31	Rs27.73 Million ≈ $299.89K	--

Equity Component Analysis

This analysis shows how different components contribute to Vaishali Pharma Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2026)

Component	Amount	Percentage
Common Stock	Rs260.92 Million	37.75%
Other Components	Rs430.23 Million	62.25%
Total Equity	Rs691.15 Million	100.00%

Vaishali Pharma Limited Competitors by Market Cap

The table below lists competitors of Vaishali Pharma Limited ranked by their market capitalization.

Company	Market Cap
Eastern Technical Engineering Public Company Limited BK:ETE	$10.82 Million
Welcron Hantec Co.Ltd KQ:076080	$10.82 Million
Bawat Water Technologies AB ST:BAWAT	$10.83 Million
Mercury Industries Bhd KLSE:8192	$10.83 Million
hGears AG XETRA:HGEA	$10.82 Million
Opus One Resources Inc V:OOR	$10.82 Million
Immolease Trust NV BR:DIEG	$10.81 Million
Trinity Biotech plc NASDAQ:TRIB	$10.81 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Vaishali Pharma Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 649,161,000 to 691,153,000, a change of 41,992,000 (6.5%).
Net income of 41,648,000 contributed positively to equity growth.
Other comprehensive income decreased equity by 1,840,999.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	Rs41.65 Million	+6.03%
Other Comprehensive Income	Rs-1.84 Million	-0.27%
Other Changes	Rs2.18 Million	+0.32%
Total Change	Rs-	6.47%

Book Value vs Market Value Analysis

This analysis compares Vaishali Pharma Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.44x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 2.92x to 1.44x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-03-31	Rs2.63	Rs7.67	x
2014-03-31	Rs2.91	Rs7.67	x
2015-03-31	Rs3.07	Rs7.67	x
2016-03-31	Rs3.09	Rs7.67	x
2017-03-31	Rs3.67	Rs7.67	x
2018-03-31	Rs22.76	Rs7.67	x
2019-03-31	Rs20.29	Rs7.67	x
2020-03-31	Rs20.27	Rs7.67	x
2021-03-31	Rs21.26	Rs7.67	x
2022-03-31	Rs24.99	Rs7.67	x
2023-03-31	Rs36.28	Rs7.67	x
2024-03-31	Rs37.21	Rs7.67	x
2025-03-31	Rs44.10	Rs7.67	x
2026-03-31	Rs5.31	Rs7.67	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Vaishali Pharma Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 6.03%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 3.83%
• Asset Turnover: 0.88x
• Equity Multiplier: 1.79x
Recent ROE (6.03%) is below the historical average (7.51%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	21.64%	0.51%	2.45x	17.52x	Rs3.23 Million
2014	9.78%	0.25%	2.26x	17.38x	Rs-68.60K
2015	4.99%	0.17%	2.06x	14.16x	Rs-1.62 Million
2016	-0.93%	-0.05%	1.34x	15.30x	Rs-3.56 Million
2017	17.16%	1.00%	1.48x	11.54x	Rs2.77 Million
2018	3.87%	1.22%	1.02x	3.12x	Rs-12.63 Million
2019	3.33%	0.98%	1.05x	3.21x	Rs-14.26 Million
2020	0.15%	0.06%	0.88x	3.10x	Rs-21.05 Million
2021	4.67%	1.95%	0.62x	3.84x	Rs-11.96 Million
2022	15.27%	5.31%	0.93x	3.10x	Rs13.88 Million
2023	16.29%	9.48%	0.88x	1.95x	Rs25.50 Million
2024	1.68%	0.83%	1.08x	1.87x	Rs-35.65 Million
2025	1.26%	0.83%	0.90x	1.69x	Rs-56.74 Million
2026	6.03%	3.83%	0.88x	1.79x	Rs-27.47 Million

Industry Comparison

This section compares Vaishali Pharma Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $41,118,163,484
Average return on equity (ROE) among peers: 13.86%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Vaishali Pharma Limited (VAISHALI)	Rs691.15 Million	21.64%	0.79x	$10.82 Million
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)	$366.97 Million	3.51%	2.41x	$25.11 Million
Aarti Drugs Limited (AARTIDRUGS)	$1.23 Billion	12.93%	2.27x	$365.36 Million
Aarti Pharmalabs Limited (AARTIPHARM)	$2.31 Million	-8.08%	0.08x	$645.54 Million
Abbott India Limited (ABBOTINDIA)	$2.31 Billion	29.62%	0.43x	$6.01 Billion
Ajanta Pharma Limited (AJANTPHARM)	$32.64 Billion	21.83%	0.24x	$4.15 Billion
Akums Drugs and Pharmaceutical (AKUMS)	$7.23 Billion	13.11%	3.52x	$996.26 Million
Alkem Laboratories Limited (ALKEM)	$75.58 Billion	20.97%	0.52x	$6.95 Billion
Amrutanjan Health Care Limited (AMRUTANJAN)	$1.09 Billion	18.92%	0.29x	$170.62 Million
Alembic Pharmaceuticals Limited (APLLTD)	$22.20 Billion	18.58%	0.77x	$1.59 Billion
Aurobindo Pharma Limited (AUROPHARMA)	$268.52 Billion	7.18%	0.49x	$8.98 Billion

About Vaishali Pharma Limited

NSE:VAISHALI India Drug Manufacturers - Specialty & Generic

Market Cap

$10.82 Million

Rs1.00 Billion INR

Market Cap Rank

#26848 Global

#1502 in India

Share Price

Rs7.67

Change (1 day)

+2.95%

52-Week Range

Rs4.88 - Rs13.15

All Time High

Rs42.57